GEHC · GE HealthCare Technologies Inc.
$65.762026-07-21Sector: Healthcare; Industry: Medical - Healthcare Information Services; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$98
+48.4% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($92 · $102) Analysts Range ($65 · $91) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $19.6B | — | 13.7% | 30.3% | $1.9B | −$76MM | $1.8B | 7.7% | — | 10.5% | $17.9B | $3.43 | — |
| 2024.Q4 | $19.6B | 0.0% | 13.7% | 20.6% | $2.1B | −$399MM | $1.7B | 9.4% | — | 11.8% | $18.3B | $3.43 | — |
| 2025.Q1 | $19.7B | 0.6% | 14.7% | 18.5% | $2.4B | −$1.0B | $1.4B | 8.2% | — | 12.5% | $19.6B | $4.36 | — |
| 2025.Q4 | $19.7B | 0.0% | 14.7% | 20.9% | $2.3B | −$913MM | $1.4B | 9.5% | — | 11.6% | $19.8B | $4.36 | — |
| 2026.Q1 | $20.0B | 1.4% | 13.7% | 22.4% | $2.1B | −$677MM | $1.4B | 7.9% | — | 10.0% | $22.5B | $3.29 | 11.0 |
| italics below = DCF projection · 10yr Rev CAGR: 5.3% |
| 2027.Q1 | $22.1B | +10.5% | 14.8% | 22.2% | $2.5B | −$2.4B | $169MM | 8.1% | $156MM | 10.8% | $24.8B | $5.05 | 13.0 |
| 2028.Q1 | $23.1B | +4.7% | 14.8% | 21.9% | $2.7B | −$1.2B | $1.5B | 8.1% | $1.3B | 10.5% | $26.0B | $5.30 | 12.4 |
| 2029.Q1 | $24.3B | +5.1% | 14.8% | 21.7% | $2.8B | −$1.3B | $1.5B | 8.2% | $1.2B | 10.6% | $27.4B | $5.59 | 11.8 |
| 2030.Q1 | $25.6B | +5.4% | 14.8% | 21.4% | $3.0B | −$1.5B | $1.5B | 8.2% | $1.1B | 10.6% | $28.9B | $5.91 | 11.1 |
| 2031.Q1 | $26.9B | +5.2% | 14.8% | 21.2% | $3.1B | −$1.5B | $1.6B | 8.3% | $1.1B | 10.6% | $30.4B | $6.24 | 10.5 |
|
| Term. Yr+ | $34.9B | 4.1% | 19.3% | 20.0% | $5.4B | −$1.7B | $3.7B | 8.6% | $37.1B | 13.1% | — | — | — |
Active scenario IV: $98 (+48.4% vs market)